Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy?
AbstractMicroarrays have replaced conventional karyotyping as a first-tier test for unbalanced chromosome anomalies in postnatal cytogenetics mainly due to their unprecedented resolution facilitating the detection of submicroscopic copy number changes at a rate of 10–20% depending on indication for testing. A number of studies have addressed the performance of microarrays for chromosome analyses in high risk pregnancies due to abnormal ultrasound findings and reported an excess detection rate between 5% and 10%. In low risk pregnancies, clear pathogenic copy number changes at the submicroscopic level were encountered in 1% or less. Variants of unclear clinical significance, unsolicited findings, and copy number changes with variable phenotypic consequences are the main issues of concern in the prenatal setting posing difficult management questions. The benefit of microarray testing may be limited in pregnancies with only moderately increased risks (advanced maternal age, positive first trimester test). It is suggested to not change the current policy of microarray application in prenatal diagnosis until more data on the clinical significance of copy number changes are available. View Full-Text
Share & Cite This Article
Miny, P.; Wenzel, F.; Tercanli, S.; Filges, I. Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy? Microarrays 2013, 2, 304-317.
Miny P, Wenzel F, Tercanli S, Filges I. Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy? Microarrays. 2013; 2(4):304-317.Chicago/Turabian Style
Miny, Peter; Wenzel, Friedel; Tercanli, Sevgi; Filges, Isabel. 2013. "Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy?" Microarrays 2, no. 4: 304-317.